EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the immune landscape and drug prediction of an M2 tumor‐associated macrophage‐related gene signature in EGFR ‐negative lung adenocarcinoma

Yajie Huang iD, Yaozhong Zhang, Xiaoyang Duan, Ran Hou, Qi Wang, Jian Shi

Thoracic Cancer · 2024

DOI: 10.1111/1759-7714.15375 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thoracic Cancer, 2024. Verfasst von Yajie Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms, Tumor-Associated Macrophages, ErbB Receptors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Commission Medical Science Research Project of Hebei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Improving immunotherapy efficacy for EGFR‐negative lung adenocarcinoma (LUAD) patients remains a critical challenge, and the therapeutic effect of immunotherapy is largely determined by the tumor microenvironment (TME). Tumor‐associated macrophages (TAMs) are the top‐ranked immune infiltrating cells in the TME, and M2‐TAMs exert potent roles in tumor promotion and chemotherapy resistance. An M2‐TAM‐based prognostic signature was constructed by integrative analysis of single‐cell RNA‐seq (scRNA‐seq) and bulk RNA‐seq data to reveal the immune landscape and select drugs in EGFR‐negative LUAD.

Methods

M2‐TAM‐based biomarkers were obtained from the intersection of bulk RNA‐seq data and scRNA‐seq data. After consensus clustering of EGFR‐negative LUAD into different clusters based on M2‐TAM‐based genes, we compared the prognosis, clinical features, estimate scores, immune infiltration, and checkpoint genes among the clusters. Next, we combined univariate Cox and LASSO regression analyses to establish an M2‐TAM‐based prognostic signature.

Results

CCL20, HLA‐DMA, HLA‐DRB5, KLF4, and TMSB4X were verified as prognostic M2‐like TAM‐related genes by univariate Cox and LASSO regression analyses. IPS and TMB analyses revealed that the high‐risk group responded better to common immunotherapy.

Conclusion

The study shows the potential of the M2‐like TAM‐related gene signature in EGFR‐negative LUAD, explores the immune landscape based on M2‐like TAM‐related genes, and predict immunotherapy response of patients with EGFR‐negative LUAD, providing a new insight for individualized treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungLung NeoplasmsTumor-Associated MacrophagesErbB ReceptorsHumansPrognosisTumor MicroenvironmentMaleFemaleBiomarkers, TumorKruppel-Like Factor 4Gene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

EGFR‐negative lung adenocarcinomabulk RNA‐seqimmune landscapesingle‐cell RNA‐seqtumor‐associated macrophage

Substanzen

ErbB ReceptorsEGFR protein, humanBiomarkers, TumorKruppel-Like Factor 4

Autor:innen und Institutionen

  • Department of Medical Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Department of Infectious Diseases, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Department of Endoscopy, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.

ORCID-Profile: Yajie Huang

Förderung

  • Health Commission Medical Science Research Project of Hebei Province

Zitieren

APA

Huang, Y., Zhang, Y., Duan, X., Hou, R., Wang, Q., & Shi, J. (2024). Exploring the immune landscape and drug prediction of an M2 tumor‐associated macrophage‐related gene signature in EGFR ‐negative lung adenocarcinoma. Thoracic Cancer. https://doi.org/10.1111/1759-7714.15375

Vancouver

Huang Y, Zhang Y, Duan X, Hou R, Wang Q, Shi J. Exploring the immune landscape and drug prediction of an M2 tumor‐associated macrophage‐related gene signature in EGFR ‐negative lung adenocarcinoma. Thoracic Cancer. 2024. doi:10.1111/1759-7714.15375

BibTeX
@article{Huang2024,
  author = {Huang, Yajie and Zhang, Yaozhong and Duan, Xiaoyang and Hou, Ran and Wang, Qi and Shi, Jian},
  title = {Exploring the immune landscape and drug prediction of an M2 tumor‐associated macrophage‐related gene signature in EGFR ‐negative lung adenocarcinoma},
  journal = {Thoracic Cancer},
  year = {2024},
  doi = {10.1111/1759-7714.15375}
}
Kostenlos starten →